Search results
Why Roche Holdings Stock Popped Today
Motley Fool via Yahoo Finance· 2 months agoShares of Swiss pharmaceuticals giant Roche Holdings (OTC: RHHBY) stock popped 2.5% in early trading Thursday before giving back about half of its gains....
Drug Giant Roche Skids As Covid Products Decline Weighs On Sales, Guidance
Investor's Business Daily· 8 months agoRoche stock skidded early Thursday after the Swiss drugmaker said declining demand for Covid...
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
Investor's Business Daily· 11 months agoRoche unveiled positive results Thursday for a rival to TG Therapeutics' one-hour infusion for...
Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout
Investor's Business Daily· 8 months agoSwiss drugmaker Roche said Monday it has agreed to buy an experimental immunology drug from Roivant...
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Motley Fool· 1 year agoRoche Holding (OTC: RHHBY) and Gilead Sciences (NASDAQ: GILD) both saw increased sales during the...
Roche Stock Rises On $3.1 Billion Deal For Obesity Drugmaker
Investor's Business Daily· 6 months agoRoche said Monday it will spend up to $3.1 billion to acquire Carmot Therapeutics, a biotech firm...
Roche CFO flags need to bolster late-stage drug development
Reuters via Yahoo News· 11 months agoSwiss drugmaker Roche needs to have better drug development projects in advanced stages to bolster...
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive via Yahoo Finance· 6 months agoRoche on Monday agreed to acquire biotechnology company Carmot Therapeutics in a deal that bulks up...
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Zacks via Yahoo Finance· 2 months agoRoche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue...
Drug Heavyweights GSK, Roche Topple As Covid Weighs On Sales Growth
Investor's Business Daily· 1 year agoEuropean pharmaceutical giants GSK and Roche leaned on vaccine and pharma sales, respectively, to...